The Community

September 2006
Pharmaceutical Representative;Sep2006, Vol. 36 Issue 9, p56
The article presents information on recent developments related to the pharmaceutical industry. The 2005 All Star award of the Illinois-based pharmaceutical company Abbott Laboratories Inc. have been given to Dave Manuel, Jack Norton, Ken Kusmider and Scott Burnam. Tony Curcio has been appointed as central regional business unit manager of the Birmingham, Alabama-based Axcan Pharma Inc.


Related Articles

  • The Community.  // Pharmaceutical Representative;Apr2006, Vol. 36 Issue 4, p60 

    The article presents several companies in the pharmaceutical industry in the U.S. The companies include Abbott Laboratories Inc., Axcan Pharma Inc., Boehringer Ingelheim Corp., and King Pharmaceuticals Inc. These companies conducted promotions including the deployment of primary care...

  • Abbott Laboratories Quennsborough is 'Numero Uno'  // Pharmaceutical Technology Europe;Aug2002, Vol. 14 Issue 8, p10 

    Reports on the Numero Uno award received by Abbot Laboratories Queenborough company, the British subsidiary of Abbot Laboratories Ltd. Factors which contributed to the success of Abbot Queenborough; Goal of the Numero Uno award.

  • NEW FORMULATIONS.  // Drug Topics;10/10/2005, Vol. 149 Issue 19, p90 

    Reports on developments involving companies in the pharmaceutical industry in the U.S. Launch of Axcan Pharma Inc.'s Canasa suppository in 1000-milligram strength for ulcerative proctitis; Approval given to a sugar-free formulation of Actiq CII from Cephalon Inc.

  • Salix Vote Looms, and Axcan Might Walk. Cecil, Mark // Mergers & Acquisitions Report;6/16/2003, Vol. 16 Issue 24, p1 

    Reports on the rejection of the bid of Axcan Pharma Inc. to acquire Salix Pharmaceuticals Ltd. in May 2003. Amount of shares held by Axcan in Salix; Implication of Salix's decision to reject the offer.

  • Recently Approved.  // Pharmaceutical Representative;Dec2006, Vol. 36 Issue 12, p14 

    The article reports on the approval of drugs by the U.S. Food and Drug Administration. The agency has approved the new indication for Avastin® from Genentech Inc. as a treatment for non-small cell lung cancer. Brovana™ from Sepracor Inc. has been approved for long-term maintenance...

  • The Community.  // Pharmaceutical Representative;Apr2005, Vol. 35 Issue 4, p57 

    Reports on executive changes in the pharmaceutical industry. Responsibilities of Greg Macdonald as a regional sales trainer of Axcan Pharma; Promotion of Diane Norman, first to executive sales consultant and then to sales district manager of Berlex Laboratories.

  • Axcan To Salix: You're Not the Only Takeout Game in Town. Cecil, Mark // Mergers & Acquisitions Report;5/19/2003, Vol. 16 Issue 20, p11 

    Compares merger and acquisition plates between Axcan Pharma Inc. and Salix Pharmaceuticals Inc. as of May 2003. Plans of Axcan with regard to acquisitions; Launch of the bid of Axcan for Salix; Completion of an offering in convertible subordinate notes by Axcan.

  • Abbott Laboratories.  // Formulary;Oct2000 Resource Guide, Vol. 35 Issue 10, p5 

    Features the Abbott Laboratories, a pharmaceutical manufacturer. Five focus areas of its pharmaceutical research and development; Plans to invest for pharmaceutical research and development; Contributions of TAP Pharmaceuticals to Abbott's product portfolio; Expansion of Abbott's portfolio...

  • Abbott set to stock medicine cabinet. Somasundaram, Meera // Crain's Chicago Business;02/01/99, Vol. 22 Issue 5, p1 

    Reports on North Chicago, Illinois-based Abbott Laboratories' plan to bolster its pharmaceuticals division by entering the acquisition market. Company's growth strategy under the leadership of Miles White; Company's decision to suspend its stock buyback program to make way for deals using the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics